Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY Complete
2015 R33 RFA-CA-14-004 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2018 R33 RFA-CA-17-013 INCE, TAN A. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers Complete
2022 R33 CA21-004 NAEGLE, KRISTEN M UNIVERSITY OF VIRGINIA A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides Active
2010 R33 RFA-CA-09-007 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT DISCOVERY PLATFORM FOR CANCER ANTIGENS Complete
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES NCE
2021 R33 CA20-018 WEI, WEI INSTITUTE FOR SYSTEMS BIOLOGY Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2013 R33 RFA-CA-13-002 HSIAO, SHIH-CHIA ADHEREN, INC. THE DEVELOPMENT OF A MICROSCOPY-BASED CELL-ARRAY TOXICITY ASSAY FOR QUANTIFYING C Complete
2019 R33 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Active
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA HOW DO COLORECTAL CANCERS ARISE DESPITE SURVEILLANCE? Complete
2008 R33 RFA-CA-07-034 POOLE, LESLIE B. WAKE FOREST UNIVERSITY HEALTH SCIENCES PROTEOMIC PROFILING OF CANCER-RELATED REDOX SIGNALING PATHWAYS Complete
2015 R33 RFA-CA-14-004 ZHU, HENG JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF A VIRION DISPLAY (VIRD) ARRAY TO PROFILE HUMAN GPCR INTERACTIONS Complete
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity NCE
2021 R33 CA20-018 CHENG, JI-XIN BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy Complete
2006 R41 RFA-CA-06-006 HIRSCHOWITZ, EDWARD A 20/20 GENESYSTEMS, INC. AUTO-ANTIBODY PROFILING OF NON-SMALL CELL LUNG CANCER Complete
1999 R41 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2000 R41 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete
2000 R41 PAR-98-066 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2000 R41 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2003 R41 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2003 R41 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R41 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2008 R42 RFA-CA-07-044 SAXENA, SATYA PRAKASH CALIBRANT BIOSYSTEMS, INC. VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS Complete
2006 R42 RFA-CA-05-006 BAO, GANG VIVONETICS, INC. IN VIVO GENE DETECTION FOR CANCER ANALYSIS Complete
2002 R42 PAR-99-101 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION Complete
2004 R42 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2009 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2007 R42 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2010 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2000 R43 PAR-99-101 RENARD, ANDRE INTERGEN COMPANY PYRENE-CONTAINING PROBES FOR MUTATION DETECTION Complete
2002 R43 PAR-01-105 MC GARRITY, GERARD J. INTRONN, INC. PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER Complete
2018 R43 PAR-18-303 LEE, LY JAMES NANOMATERIAL INNOVATION, LTD Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis Complete
1999 R43 PAR-98-066 CRONIN, MAUREEN T. PROTOGENE LABORATORIES, INC. DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD Complete
2017 R43 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2000 R43 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2018 R43 PAR-18-303 SCHOETTLE, LOUIS GEMNEO BIOSCIENCE, INC. Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes Complete
1999 R43 PAR-98-066 WIKTOR, PETER J. ENGINEERING ARTS PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS Complete
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2000 R43 PAR-99-101 CHO, RAYMOND JAIHYUN INGENUITY SYSTEMS, INC. FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2005 R43 RFA-CA-05-006 KIM, RAYMOND GENEPRISM, INC. MULTIPLEXED PROTEIN BIOCHIP ASSAYS--SIGNAL AMPLIFICATION Complete
2019 R43 PAR-18-303 KASOJI, SANDEEP TRIANGLE BIOTECHNOLOGY, INC. SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples Complete
1999 R43 PAR-98-066 BEACH, DAVID H. GENETICA, INC. TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS Complete

Pages